世界の分子細胞遺伝学市場 – 業界動向と2030年までの予測

分子細胞遺伝学市場の分析と規模

WHO によると、がんは死亡原因の 1 つであり、2030 年には世界中で 1,150 万人ががんで亡くなると予想されています。肺がんは、男性、女性を問わず死亡原因の第 1 位です。現在、がん診断用のキットは数多く市販されていますが、膀胱がんの早期発見に使用できるのは Abbott Molecular の UroVysion 膀胱がんキットのみです。同様に、市販の検出キットには、乳がん用の PathVysion、血液疾患用の Vysis CLL FISH プローブキットなどがあります。

Data Bridge Market Research は、2022 年に 27 億 6,000 万米ドルであった分子細胞遺伝学市場は、2023 年から 2030 年の予測期間中に 9.7% の CAGR で成長し、2030 年には 58 億米ドルに達すると予測しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Research がまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

分子細胞遺伝学市場の範囲とセグメンテーション  

Market Definition

Molecular cytogenetic combines molecular biology and cytogenetics. Cytogenetics is the study of chromosomes, and molecular cytogenetics is the analysis of genetic variations or alterations using in-situ hybridization techniques. Molecular cytogenetics has critical applications in biology and medicine. Molecular cytogenetics is the study of the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities, particularly in medicinal and cancer genetics. Techniques such as fluorescence in situ hybridization (FISH) are used in molecular cytogenetics to visualize the entire genome or specific regions of the genome.

Global Molecular Cytogenetic Market Dynamics

Drivers

• Increase in R&D Activities

The large number of research centres in China and India and R&D centres in Japan will increase demand for high-quality molecular cytogenetics. Japan is the leading contributor to the global molecular cytogenetics market, owing to long-standing collaborations between manufacturers and research institutions. Furthermore, personalized medicine's role in treating genetic or other disorders is gaining traction in developed countries, which is expected to boost the market during the forecast period.

• Increasing prevalence of cancer 

Cancer diagnostics primarily drives molecular cytogenetics, and it provides techniques for imaging in genetics, epigenetics, and cytology, as well as the ability to detect chromosomal changes. The rising prevalence of cancer and the resulting need for accurate diagnosis are expected to drive the global molecular cytogenetic market between 2023 and 2030.

Opportunities

• Technically advance healthcare sector

The rising government and private healthcare spending, and improved healthcare infrastructure in this region all contribute to the growth of the molecular cytogenetic market. For instance, a woman in the United States has a 13% chance of developing breast cancer in her lifetime. In 2018, an estimated 234,030 new cases of lung cancer were discovered, and 541,000 Americans have been diagnosed with the disease at some point in their lives. These findings demonstrate the enormous potential for growth and expansion in the molecular cytogenetic market.

Restraints/Challenges

• Lack of Skilled professional

Some factors, such as technical limitations and complexities associated with the equipment, are expected to impede the growth of the molecular cytogenetic market during the forecast period. However, the high cost of cytogenetic instruments and a lack of awareness about advanced technological methodologies, particularly in low and middle-income countries, are expected to hamper market growth during the forecast period.

This molecular cytogenetic market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the molecular cytogenetic market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Molecular Cytogenetic Market

COVID-19 is expected to have a significant impact on the market. Around the world, there have been several changes in consumer demand and behaviour, purchasing habits, and significant government initiatives. The COVID-19 has altered the population's nutrition, substance use and health-related behaviours. Furthermore, as COVID-19 spreads around the world, hospitalization rates are dropping dramatically. Several reports indicated that many hospitals were operating at less than 50% capacity in order to reduce noncritical medical services and elective surgeries. As a result, COVID-19 is expected to have a large impact on the molecular cytogenetic market.

Recent Developments

• In August 2022, Agilent Technologies Inc. announced the acquisition of Polymer Standards Service GmbH (PSS), a provider of polymer characterization solutions. PSS specializes in hardware and software solutions for defining molecular structure makeup and creation. The company offers complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC), which are used to determine the molecular weight and size distribution of macromolecules in applications.

Global Molecular Cytogenetic Market Scope

The molecular cytogenetic market is segmented on the basis of technique, product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Fluorescence In Situ Hybridization
•  Comparative Genomic Hybridization
• Array-based comparative genomic hybridization
• Standard comparative genomic hybridization
•  In situ Hybridization
•  Karyotyping
• Spectral karyotyping
• Virtual karyotyping
• Banding Techniques
• G banding
• Q banding
•  R banding
•  C banding
• T banding

 Product

• Instruments
•  Kits and Reagents
• Testing kits
• probes
• Fluorescent affinity reagents
• Others
•  Software and Services
•  Consumables/Accessories

Application

• Oncology
•  Genetic Disorders
• Personalized Medicines
• Others

 End User

• Pharmaceuticals and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Academic Institutes

Molecular Cytogenetic Market Regional Analysis/Insights

The molecular cytogenetic market is analyzed and market size insights and trends are provided by country, technique, product, application and end user as referenced above.

The countries covered in the molecular cytogenetic market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the molecular cytogenetic market due to the presence of an effective regulatory framework for the regulation of genetic tests along with the strong presence of major entities in this particular region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the advancements in human genetics and disease management, as well as the unrelenting GDP growth of emerging countries such as China and India, are likely to increase consumer purchasing power in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Molecular Cytogenetic Market Share Analysis

分子細胞遺伝学市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、分子細胞遺伝学市場に関連する会社の焦点にのみ関連しています。

分子細胞遺伝学市場で活動している主要企業は次のとおりです。

• F.ホフマン・ラ・ロシュ社（スイス）
• ダナハー（米国）
• サーモフィッシャーサイエンティフィック株式会社（米国）
• アボット（米国）
• アジレントテクノロジー社（米国）
• パーキンエルマー社（米国）
• イルミナ社（米国）
• バイオ・ラッド・ラボラトリーズ社（米国）
• オックスフォード ジーン テクノロジー IP リミテッド (英国)
• アプライド スペクトラル イメージング社 (米国)
• ザルトリウスAG（ドイツ）
• CytoTest Inc. (米国)
• Cytognomix, Inc. (カナダ)
• バイオナノ・ゲノミクス（米国）
• Precipio（米国）
• ライカバイオシステムズヌスロッホ GmbH (ドイツ)

調査方法: 世界の分子細胞遺伝学市場

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせ内容をドロップダウンしてください。

DBMR リサーチ チームが使用する主要なリサーチ手法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これ以外にも、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。リサーチ手法について詳しくは、お問い合わせフォームから当社の業界の専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合ったデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、再開発市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社を必要なだけ追加し、必要な形式とデータ スタイルでデータを作成できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

SKU-57193